129 related articles for article (PubMed ID: 18468739)
1. Cellular and humoral immune responses to chimeric EGFP-pseudocapsids derived from the mouse polyomavirus after their intranasal administration.
Fric J; Marek M; Hrusková V; Holán V; Forstová J
Vaccine; 2008 Jun; 26(26):3242-51. PubMed ID: 18468739
[TBL] [Abstract][Full Text] [Related]
2. VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model.
Vlastos A; Andreasson K; Tegerstedt K; Holländerová D; Heidari S; Forstová J; Ramqvist T; Dalianis T
J Med Virol; 2003 Jun; 70(2):293-300. PubMed ID: 12696121
[TBL] [Abstract][Full Text] [Related]
3. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
[TBL] [Abstract][Full Text] [Related]
4. Polyomavirus EGFP-pseudocapsids: analysis of model particles for introduction of proteins and peptides into mammalian cells.
Boura E; Liebl D; Spísek R; Fric J; Marek M; Stokrová J; Holán V; Forstová J
FEBS Lett; 2005 Dec; 579(29):6549-58. PubMed ID: 16298367
[TBL] [Abstract][Full Text] [Related]
5. A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of HER-2/neu-expressing tumors.
Tegerstedt K; Lindencrona JA; Curcio C; Andreasson K; Tullus C; Forni G; Dalianis T; Kiessling R; Ramqvist T
Cancer Res; 2005 Jul; 65(13):5953-7. PubMed ID: 15994974
[TBL] [Abstract][Full Text] [Related]
6. Murine polyomavirus-VP1 virus-like particles immunize against some polyomavirus-induced tumours.
Franzén AV; Tegerstedt K; Holländerova D; Forstová J; Ramqvist T; Dalianis T
In Vivo; 2005; 19(2):323-6. PubMed ID: 15796193
[TBL] [Abstract][Full Text] [Related]
7. Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus.
Li YG; Tian FL; Gao FS; Tang XS; Xia C
Vaccine; 2007 Jan; 25(5):902-11. PubMed ID: 17028078
[TBL] [Abstract][Full Text] [Related]
8. Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells.
Gedvilaite A; Dorn DC; Sasnauskas K; Pecher G; Bulavaite A; Lawatscheck R; Staniulis J; Dalianis T; Ramqvist T; Schönrich G; Raftery MJ; Ulrich R
Virology; 2006 Oct; 354(2):252-60. PubMed ID: 16904154
[TBL] [Abstract][Full Text] [Related]
9. Induction of T cell tolerance to a protein expressed in the cytoplasm through retroviral-mediated gene transfer.
Tian C; Bagley J; Kaye J; Iacomini J
J Gene Med; 2003 May; 5(5):359-65. PubMed ID: 12731084
[TBL] [Abstract][Full Text] [Related]
10. Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer.
Tegerstedt K; Franzén AV; Andreasson K; Joneberg J; Heidari S; Ramqvist T; Dalianis T
Anticancer Res; 2005; 25(4):2601-8. PubMed ID: 16080500
[TBL] [Abstract][Full Text] [Related]
11. Minor capsid proteins of mouse polyomavirus are inducers of apoptosis when produced individually but are only moderate contributors to cell death during the late phase of viral infection.
Huerfano S; Zíla V; Boura E; Spanielová H; Stokrová J; Forstová J
FEBS J; 2010 Mar; 277(5):1270-83. PubMed ID: 20121946
[TBL] [Abstract][Full Text] [Related]
12. Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant.
Crisci E; Almanza H; Mena I; Córdoba L; Gómez-Casado E; Castón JR; Fraile L; Bárcena J; Montoya M
Virology; 2009 May; 387(2):303-12. PubMed ID: 19327809
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide stimulation of dendritic cells induces interleukin-10 producing allergen-specific T cells in vitro but fails to prevent allergic airway disease.
Ahrens B; Freund T; Rha RD; Dittrich AM; Quarcoo D; Hutloff A; Hamelmann E
Exp Lung Res; 2009 May; 35(4):307-23. PubMed ID: 19415548
[TBL] [Abstract][Full Text] [Related]
14. Bcr-Abl fusion sequences do not induce immune responses in mice when administered in mouse polyomavirus based virus-like particles.
Hrusková V; Morávková A; Babiarová K; Ludvíková V; Fric J; Vonka V; Forstová J
Int J Oncol; 2009 Dec; 35(6):1247-56. PubMed ID: 19885546
[TBL] [Abstract][Full Text] [Related]
15. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.
Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R
Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983
[TBL] [Abstract][Full Text] [Related]
16. Cellular and humoral immunogenicity of hamster polyomavirus-derived virus-like particles harboring a mucin 1 cytotoxic T-cell epitope.
Dorn DC; Lawatscheck R; Zvirbliene A; Aleksaite E; Pecher G; Sasnauskas K; Ozel M; Raftery M; Schönrich G; Ulrich RG; Gedvilaite A
Viral Immunol; 2008 Mar; 21(1):12-27. PubMed ID: 18355119
[TBL] [Abstract][Full Text] [Related]
17. Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor.
Du Y; Jiang P; Li Y; He H; Jiang W; Wang X; Hong W
Vaccine; 2007 Nov; 25(49):8209-19. PubMed ID: 17980939
[TBL] [Abstract][Full Text] [Related]
18. A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines.
Middelberg AP; Rivera-Hernandez T; Wibowo N; Lua LH; Fan Y; Magor G; Chang C; Chuan YP; Good MF; Batzloff MR
Vaccine; 2011 Sep; 29(41):7154-62. PubMed ID: 21651936
[TBL] [Abstract][Full Text] [Related]
19. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Brandenburg S; Takahashi T; de la Rosa M; Janke M; Karsten G; Muzzulini T; Orinska Z; Bulfone-Paus S; Scheffold A
Eur J Immunol; 2008 Jun; 38(6):1643-53. PubMed ID: 18493984
[TBL] [Abstract][Full Text] [Related]
20. Type I Interferons Regulate the Magnitude and Functionality of Mouse Polyomavirus-Specific CD8 T Cells in a Virus Strain-Dependent Manner.
Qin Q; Shwetank ; Frost EL; Maru S; Lukacher AE
J Virol; 2016 May; 90(10):5187-99. PubMed ID: 26984726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
